Stock BAFNAPH BAFNA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Bafna Pharmaceuticals Limited

Equities

BAFNAPH

INE878I01022

End-of-day quote NSE India S.E.
Other stock markets
 23:00:00 12/05/2024 BST 		5-day change 1st Jan Change
99.6 INR -4.96% Intraday chart for Bafna Pharmaceuticals Limited -4.96% +8.26%
04-26 Bafna Pharmaceuticals Limited Announces the Inauguration of New Quality Control Laboratory CI
04-23 Bafna Pharmaceuticals Limited Announces Resignation of Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bafna Pharmaceuticals Limited Announces the Inauguration of New Quality Control Laboratory
CI
Bafna Pharmaceuticals Limited Announces Resignation of Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer
CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Bafna Pharmaceuticals Resumes Commercial Production of Manufacturing Units in Chennai, India
MT
Bafna Pharmaceuticals Limited Announces Commercial Production
CI
Floods Disrupt Bafna Pharmaceuticals' Manufacturing Plant in Chennai, India
MT
Bafna Pharmaceuticals Limited Announces Suspension of Chennai Production Activity Due to Impact of Michaung Cyclone
CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Bafna Pharmaceuticals Limited Announces Resignation of Kamlesh Kumar Babulal as Non-Executive Independent Director from the Board
CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Bafna Pharmaceuticals Limited Approves Board Appointment
CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Bafna Pharmaceuticals Limited Announces Appointment Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer
CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Bafna Pharmaceuticals Limited Announces Resignation of Atul Sachdeva as Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAFNAPH Stock
  4. News Bafna Pharmaceuticals Limited